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We investigated whether oral lactate could prevent seizures and deaths in mice with severe hypoglycemia 
induced by a high dose of insulin. For this purpose, mice were fasted for 15 h and then given an 
intraperitoneal injection of regular insulin (5.0 U/kg or 10.0 U/kg). Immediately after insulin injection, 
the mice received an oral dose of saline (control), glucose (5.5 mmol/kg), or lactate (18.0 mmol/kg). 
Glucose and lactate levels were measured in the blood and brain before and after the seizures began. 
Glucose and lactate delayed (p < 0.05) the onset of seizures associated with severe insulin-induced 
hypoglycemia. Elevated (p < 0.05) brain levels of lactate were associated with an absence of seizures in 
mice that received glucose or lactate, suggesting that lactate could prevent convulsions associated with 
severe insulin-induced hypoglycemia. However, the same oral dose of lactate that delayed the onset of 
convulsions also increased the mortality rate. In contrast, diazepam (3.0 mg/kg) prevented seizures and 
markedly decreased the frequency of death during severe insulin-induced hypoglycemia. The results 
demonstrated that in contrast to oral glucose, oral lactate intensifies insulin toxicity. 
Keywords: Lactatemia. Oral glucose. Diazepam. Seizure. Anticonvulsant effect. 
INTRODUCTION 
Insulin-induced hypoglycemia, the major acute 
adverse effect of insulin therapy (Sanches et al., 2013; 
Vilela et al., 2014), is clinically relevant because glucose 
is the main fuel for the brain (Bazzigaluppi et al., 2017). 
Because glucose administration has an evanescent 
effect in treating hypoglycemia, diabetes patients must 
be advised to eat regular meals to prevent a recurrence of 
insulin-induced hypoglycemia. However, during sleep, this 
method is not adequate to treat nocturnal hypoglycemia. 
In fact, nocturnal hypoglycemia associated with “dead in 
bed syndrome” is responsible for 5-6% of deaths among 
patients with type 1 diabetes (Weston, 2012). 
Therefore, it is necessary replace glucose with 
substances that are more potent and have prolonged effects. 
In this regard, the effects of glucose have previously been 
compared with those of glutamine, alanine, lactate, and 
pyruvate (Galende et al., 2009; Hartman et al., 2010; 
Nunes Santiago et al., 2013; Rodrigues et al., 2011).
Because glucose inhibits liver gluconeogenesis 
and does not alleviate hypoglycemia induced by insulin 
administration (Galende et al., 2009), liver glucose 
continues to be produced from lactate during periods 
of hypoglycemia (Hartman et al., 2010; Rodrigues et 
al., 2011). Moreover, lactate has been proposed as an 
alternative brain energy fuel (Pellerin, Magistretti, 1994, 
Wyss et al., 2011). In fact, the lactate produced from 
glucose in astrocytes is released and used by neurons. 
Thus, the concept of glucose being the main brain fuel 
remains unchanged; however, the current idea is that 
lactate produced from glucose, and not glucose per se, is 
the main energy fuel for neurons (Pellerin, Magistretti, 
1994; Pellerin, Magistretti, 2012).
When coupled with results from our previous study 
(Hartman et al., 2010; Rodrigues et al., 2011), this new 
concept concerning the role of lactate as a brain fuel 
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(Pellerin, Magistretti, 2012; Proia et al., 2016; Smith et 
al., 2003), suggests the possibility of using lactate rather 
than glucose to treat insulin induced hypoglycemia (Chan 
et al., 2013; De Feyter et al., 2013; Herzog et al., 2013; 
Oldenbeuving et al., 2014; Rooijackers et al., 2016).
Here, we evaluate the effect of oral lactate on 
the occurrence of seizures and deaths among mice that 
received high doses of insulin. To complement this 
investigation, the blood and brain levels of glucose and 
lactate, and the ability of diazepam to prevent seizures and 
deaths were also evaluated.
MATERIAL AND METHODS
Animals
The study protocol was approved by the Animal 
Ethics Committee (079-PRO 051.2011) of the State 
University of Maringá. All experimental procedures were 
performed in accordance with the Brazilian Directives 
on Research Animal Protection and Experimentation 
(11.794/2008), and reported in accordance with ARRIVE 
(Animal Research: Reporting in Vivo Experiments).
Mice (6-weeks of age) were fasted for 15 h, and 
then given a single intraperitoneal (ip) injection of regular 
insulin (Humulin®). Immediately after insulin injection, 
the mice were randomly selected to receive an oral gavage 
dose of glucose (5.5 mmol/kg), or lactate (18.0 mmol/kg), 
or a single ip dose of diazepam (3.0 mg/kg).
The doses of insulin (Deprez-Poulain et al., 
2015; Wang, Liao, 2012), glucose (Guo et al., 2015), 
lactate (Thurston, Hauhart, Schiro, 1983) and diazepam 
(Keshavars, Showraki, Emamghoreishi, 2013) were 
selected based on doses used in previous studies.
Dose response curve and seizures 
Mice were divided into 8 groups (n = 3-4 per group) 
which were given increasing ip doses of insulin: (0.5, 
1.0, 1.5, 2.0, 3.0, 4.0, 5.0, or 10.0 U/kg). Blood samples 
were collected from the tail at 0, 30, 60, 90, and 120 min 
after insulin injection, as previously described (Marques 
et al., 2016). Glycemia (mmol/L) was evaluated with a 
home glucometer (Optium Xceed®, Abbott Laboratories, 
Chicago, IL, USA), which is known to show good 
accuracy compared with the gold standard method used to 
measure plasma glucose (Robinson, Sharp, 2012). 
The results of these experiments are summarized in 
the Figure 1.
Because seizures were observed only after insulin 
was administered at a dose of 5.0 U/kg or 10.0 U/kg 
(Figure 1), those doses were chosen to evaluate the effect 
of oral glucose or lactate administration on seizures and 
deaths. 
The effects of oral glucose or lactate on seizures 
and deaths among hypoglycemic mice 
The effects of oral glucose (5.5 mmol/kg) or oral 
lactate (18.0 mmol/kg) on seizures and deaths among 
FIGURE 1 - Dose response curve and seizures. Blood glucose levels at 0, 30, 60, 90, and 120 min after an intraperitoneal injection 
(0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 5.0 or 10.0 U/Kg) of insulin into 15 h fasted mice. The mice were sacrificed when a seizure started. 
Results represent the mean ± standard error (n = 3-4). Data were analyzed using the Newman-Keuls multiple comparisons test. a 
p < 0.05 as compared to time 0; b p < 0.05 as compared to the dose (1.5 U/kg, 2.0 U/kg or 3.0 U/kg); c p < 0.05 as compared to the 
dose (5.0 U/kg or 10.0 U/kg); d p < 0.05 as compared to the dose (2.0 U/kg, 3.0 U/kg or 4.0 U/kg).
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mice that received ip insulin (5.0 U/kg or 10.0 U/kg) were 
evaluated.
Thirty mice that received a 5.0 U/kg dose of insulin 
and thirty mice that received a 10.0 U/kg dose of insulin 
were divided into the following 3 groups (n = 10 mice 
per group): insulin + saline, insulin + lactate, and insulin 
+ glucose. Saline, lactate or glucose was administered 
immediately after the insulin injection. The mice were 
them observed for a period of 300 min, which started 
immediately after an ip dose of insulin followed by an oral 
dose of saline, lactate or glucose.  
To evaluate seizures after insulin injection, each 
group of mice (10 mice per cage) was kept in a silent 
room. While in the room, data for the following parameters 
was recorded for each group of mice: the of onset of the 
first seizure; time between seizures; number of seizures; 
death rate; time of death. As previously described by 
Zhao et al. (2003), seizure was defined as when the mouse 
showed rhythmic jerks (clonic) and continuous tension or 
contraction of muscles (tonic). 
Blood and brain levels of glucose and lactate 
The blood and brain levels of glucose and lactate 
in mice that received ip insulin (10.0 U/kg) + oral saline 
(Ins group), ip insulin (10.0 U/kg) + oral lactate (Ins + Lac 
group) or ip insulin (10.0 U/kg) + oral glucose (Ins + Glc 
group) were quantified. A normoglycemic Control group 
that received ip saline and oral saline (Control group) was 
also included.
All mice (n = 6 per group) were sacrificed by 
decapitation. This method ensures a quick blood and brain 
collection without interference from anesthetics in the brain.
After decapitation, the blood was collected, 
centrifuged (10 min at 5 °C), and the plasma was kept 
on ice for subsequent evaluations of blood lactate and 
glucose levels. Lactate concentrations were measured 
using enzymatic techniques (Gutmann, Wahlefeld, 1974). 
Glucose was measured by using commercial kits.
For evaluations of brain lactate and glucose levels, 
the brains were quickly removed and stored in liquid 
nitrogen for several minutes. The brains were then 
homogenized (20 seconds) with perchloric acid containing 
EDTA (1 mM) in a van Potter-Elvehjem homogenizer; 
after which, the homogenates were placed in an ice 
bath and centrifuged at 10000 g (for 20 min at 5 °C.) 
The supernatant fractions were neutralized with KOH 
(5 mmol) containing 50 mmol triethanolamine, and then 
maintained on ice for 15 min before being centrifuged 
again (Kepler, Decker, 1974). After centrifugation, the 
supernatant lactate and glucose levels were measured 
using enzymatic techniques (Gutmann, Wahlefeld, 1974) 
and commercial kits, respectively.
The following studies were performed as two sets 
of experiments. 
In one set of experiments, the mice (n = 6 per group) 
were sacrificed when a seizure started in the Ins group 
but not in the other groups. This experimental approach 
allowed us to compare mice with a seizure (Ins group) 
and without a seizure. In the other set of experiments, 
each mouse was sacrificed when it began to convulse 
(n = 4 per group). This experimental approach allowed 
for comparisons of all mice which experienced a seizure. 
The effects of diazepam on seizures and deaths 
among mice that received ip insulin
Mice that received ip insulin (10.0 U/kg) + ip saline 
(n =9 per group) were compared with mice that received 
ip insulin (10.0 U/kg per group) + ip diazepam (3.0 mg/kg) 
(n=10 per group). The 300 min observation period started 
immediately after injection of either ip insulin + ip saline 
or ip insulin + ip diazepam.
Statistical analyses
All data were analyzed by ANOVA (Newman-Keuls 
post hoc test) using Graph-Pad Prism Version 5.0 software. 
Results are reported as the mean ± standard error (SE) of 
the mean. P-values < 0.05 were considered statistically 
significant.
RESULTS
As shown in Table I, 90%, 100%, and 80% of mice 
that received ip insulin (5.0 U/kg) plus oral saline, ip 
insulin (5.0 U/kg) plus oral lactate or ip insulin (5.0 U/kg) 
plus oral glucose, respectively, had seizures.
The number of seizures in the group that received ip 
insulin (5.0 U/kg) plus oral glucose was higher (p < 0.05) 
than those in the other groups. Moreover, the group that 
received ip insulin (5.0 U/kg) plus oral lactate had a higher 
death rate (Table I). 
Seizure rate, onset of first seizure, number of 
seizures, time between seizures, death rate, and time of 
death during the 300 min observation period after ip insulin 
injection. Oral saline, lactate or glucose was administered 
immediately after insulin injection. Data are reported as 
the mean ± standard error or a proportion (n/n). Data were 
analyzed using the Newman-Keuls multiple comparisons 
test. a p < 0.05 as compared to the Insulin + saline group; b 
p < 0.05 as compared to the Insulin + lactate group.
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As shown in Table II, all mice that received ip insulin 
(10.0 U/kg) had seizures.
Furthermore, the seizures started earlier (p < 0.05) in 
the group that received ip insulin (10.0 U/kg) + oral saline 
than in the other groups. Moreover, the group that received 
ip insulin (10.0 U/kg) + oral lactate had a higher death rate.
Seizure rate, onset of the first seizure, number of 
seizures, time between seizures, death rate, and time of 
death during the 300 min observation period following ip 
administration of insulin. Oral saline, lactate or glucose 
was administered immediately after insulin injection. 
Results are reported as the mean ± standard error or a 
proportion (n/n). Data were analyzed using the Newman-
Keuls multiple comparisons test. a p < 0.05 as compared 
to the Insulin + saline group.
Because all mice given 10.0 U/kg of insulin had 
seizures, that dose was chosen to evaluate the glucose and 
lactate levels in the blood and brain.
The data shown in Figure 2A-D, compare the blood 
and brain glucose and lactate levels of mice with a seizure 
(Ins group) and without a seizure (Ins + Glc group and Ins 
+ Lac group).
The glycemia values of all groups that received ip 
insulin were lower (p < 0.05) than those in the Control 
group (Figure 2A). Additionally, the Ins + Glc group 
had higher (p <0.05) glycemia values than the Ins group 
(Figure 2A). In contrast, the brain glucose levels were 
similar in all groups (Figure 2B).
The lactatemia values were greater (p < 0.05) in 
the Ins + Lac group than in the other groups. In contrast, 
the Control, Ins, and, Ins + Glc groups had similar blood 
lactate levels (Figure 2C). 
Moreover, the Ins group had lower (p < 0.05) brain 
lactate levels than the other groups (Figure 2D). 
The results presented in Figure 2E-H compare the 
blood and brain glucose and lactate levels of all animals 
after seizure onset in each animal; thus the levels were 
measured at variable intervals after receiving insulin. 
TABLE I - Effect of oral glucose (5.5 mmol/kg) or lactate (18.0 mmol/kg) on seizures and deaths among hypoglycemic mice that 
received intraperitoneal insulin (5.0 U/kg)
Insulin + Saline Insulin + Lactate Insulin + Glucose
Seizure rate 9/10 10/10 8/10
Onset of first seizure (min)
71.7 ± 11.7  
n = 9
100.4 ± 9.0  
n = 10
83.3 ± 6.3  
n = 8
Number of seizures 4.8 ± 1.5  n = 9
2.5 ± 0.8 
 n = 10
8.5 ± 1.1a,b  
n = 8
Time between the seizures (min) 14.5 ± 1.3  n = 5
17.5 ± 6.9 
 n = 6
21.4 ± 11.1 
n = 8
Death rate 1/10 7/10 1/10
Time of death (min) 192.8  n = 1




TABLE II - Effect of oral glucose (5.5 mmol/kg) or lactate (18.0 mmol/kg) on seizures and deaths among hypoglycemic mice that 
received intraperitoneal insulin (10.0 U/kg)
Insulin + Saline Insulin + Lactate Insulin + Glucose
Seizure rate 10/10 10/10 10/10
Onset of first seizure (min)
59.9 ± 8.1  
n = 10
109.9 ± 5.6a  
n = 10
127.8 ± 8.2a  
n = 10
Number of seizures 7.8 ± 1.1  n = 10
2.8 ± 0.3a 
 n = 10
3.7 ± 0.6a  
n = 10
Time between the seizures (min) 21.5 ± 5.9  n = 10
33.3 ± 8.2 
 n = 10
18.4 ± 3.3 
n = 10
Death rate 3/10 8/10 2/10 
Time of death (min) 191.1 ± 47.5  n = 3
186.6 ± 18.3  
n = 8
150.9 ± 19.2  
n = 2
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The glycemia (Figure 2E) and brain lactate levels 
(Figure 2H) were lower (p < 0.05) in all groups that 
received ip insulin than in the Control group. However, the 
Ins, Ins + Lac, and Ins + Glc groups showed no difference 
in their glycemia (Figure 2E), blood lactate (Figure 2G), 
brain glucose (Figure 2F) and brain lactate (Figure 2H) 
levels.
The numbers of seizures and deaths among mice that 
received ip insulin (10.0 U/kg) and mice that received ip 
insulin (10.0 U/kg) plus ip diazepam (3.0 mg/kg) were 
compared. As shown in Table III the ip administration of 
diazepam prevented seizures and decreased the death rate 
among mice that received ip insulin (10.0 U/kg).
DISCUSSION
Nocturnal hypoglycemia, especially common in type 
1 diabetic patients, is a danger for any patient being treated 
FIGURE 2 - Blood and brain levels of glucose and lactate in mice with () and without () seizures. The Control group received 
intraperitoneal (ip) saline + oral saline. The experimental groups received ip insulin + oral saline (Ins group), ip insulin + oral lactate 
(Ins and Lac group) or ip insulin + oral glucose (Ins and Glc group). Oral saline, lactate (18.0 mmol/kg) or glucose (5.5 mmol/kg) 
was administered immediately after ip saline (Control group) or insulin (10.0 U/kg). In one set of experiments (A, B, C, D; n = 6), 
the mice were sacrificed when the first seizure started in the Ins group, and while the other groups did not have seizures. In the other 
set of experiments, each mouse was sacrificed when it began seizing (E, F, G, H; n = 4). Data are reported as the mean ± standard 
error. Data were analyzed using the Newman-Keuls multiple comparison test, a p < 0.05 as compared to the Control group; b p < 
0.05 as compared to the Ins group; c P < 0.05 as compared to the Ins + Lac group; d p < 0.05 as compared to the Ins + Glc group.












Time of death 
 (min)
Insulin + Saline 9/9 67.9 ± 8.9 n = 9
7.4 ± 1.2 
n = 9
19.5 ± 4.4 
n = 9 5/9
174.9 ± 27.6 
n = 5




n = 10 1/10
172.6 ± 0 
n = 1
Seizure rate, onset of first seizure, number of seizures, time between seizures, death rate, and time of death during the 300 min 
observation period following ip administration of insulin and either ip saline or ip diazepam. Results are reported as the mean ± 
standard error or a proportion, (n/n). NA: not applicable
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by insulin because the patient is not awake and cannot take 
appropriate measures or receive help. 
In view of the vulnerability of the brain and the 
absence of suitable antidotes for nocturnal hypoglycemia, 
the possibility of using lactate to treat or prevent prolonged 
hypoglycemia must be considered.
The main reason for this proposition is based on the 
fact that not only glucose (Bazzigaluppi et al., 2017; Vilela 
et al., 2014), but also lactate (Proia et al., 2016; Wyss et 
al., 2011) are important fuels for the brain. 
Because, it remains to be clarified whether lactate 
can be used to treat hypoglycemia, we evaluated the effects 
of the oral lactate on the occurrence of seizures and deaths 
during a period of five hours, among mice that received 
high doses of insulin.
Higher (p < 0.05) brain levels of lactate (Figure 2D: 
Control, Ins + Lac or Ins + Glc groups versus Ins group) 
were associated with the absence of seizures. In addition, 
the role of brain lactate to prevent seizures was reinforced 
by the fact that when seizures began, the brain levels of 
lactate in the Ins, Ins + Lac, or Ins + Glc groups were 
lower (p < 0.05) than those in the control group (Figure 
2H). In agreement with these results, Wiegers et al. (2016) 
demonstrated that in type 1 diabetes patients, symptoms of 
insulin-induced hypoglycemia are related to the decreased 
availability of lactate in the brain.
Interestingly, hypoglycemic mice that received oral 
glucose (Ins + Glc group) or lactate (Ins + Lac group) 
had similar brain lactate levels (Figure 2D), confirming 
that oral glucose is an important source of brain lactate 
(Bazzigaluppi et al., 2017).
Despite the fact that glucose prolonged the time 
until the first seizure, mice that received glucose (Ins + 
glc group) or saline (Ins + saline group) had similar death 
rates (Tables I and II). Those results can be attributed to 
the fact that the dose of glucose was sufficient to prolong 
the time until the first seizure induced by the high doses 
(5 U/kg and 10.0 U/kg) of insulin but was not enough to 
prevent severe hypoglycemia. 
The same dose of oral lactate that delayed the onset 
of first convulsion also increased hypoglycemia-induced 
mortality (Table II and Table III). One possible explanation 
for this finding is that lactate has a low Km value, i.e., 
about 2.5 mM (Shulman, Hyder, Rothman, 2001), which 
is near its physiological level in blood. Therefore, there is 
a limitation in the transport of lactate through the blood-
brain barrier and the elevated blood lactate levels cannot 
supply the brain lactate deficit due to hypoglycemia. As 
FIGURE 3 - Scheme based on the model proposed by Pellerin and Magistretti (2012). Our hypothesis is that during severe 
hypoglycemia, the availability of glucose to astrocytes becomes sharply decreased. Thus, the amount energy produced by 
glycolysis and the release of lactate to neurons also decreases. In contrast, the concentration of glutamate increases. Because 
diazepam decreases glutamate release by enhancing GABAergic inhibition of glutamatergic neurons, we suggest that an increased 
availability of excitatory neurotransmitters can trigger glutamate toxicity, and thereby promote seizures and deaths. Furthermore, the 
decreased availability of brain lactate cannot be compensated for lactate from blood, because the brainʼs ability for lactate uptake 
is very limited. Key: GABA, gamma-aminobutyric acid; R-GABA, GABA receptor; R-Glut, glutamate receptor; GLUT, glucose 
transporter; glucose 6-P, glucose 6 phosphate; MCTs, monocarboxylate transporters; DZP, diazepam; LDH, lactate dehydrogenase; 
+, stimulation; -, inhibition; , potentiation. 
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consequence of this limitation, the elevation in blood 
lactate concentration after lactate administration (Figure 
2C) was not followed by an elevation of brain lactate 
(Figure 2D). Moreover, the decrease in brain lactate 
levels which occurred during severe insulin induced 
hypoglycemia (Figure 2H) may promote neuronal death.
Taken together, the results of the present study, 
when combined with recent reports (Newman, Korol, 
Gold, 2011; Falkowska et al., 2015; Boury-Jamot et 
al., 2016) concerning the roles of glucose, lactate, and 
glutamate in brain metabolism, permit us formulate the 
hypothesis illustrated in Figure 3. Our hypothesis, based 
on the the astrocyte-neuron lactate shuttle model (Pellerin, 
Magistretti, 2012, Shen et al., 2014), states that during 
insulin-induced hypoglycemia, there is a sharp decrease 
in the availability of glucose to the astrocytes promoting 
decreased glycosysis in these cells and reduced release of 
lactate to the neurons. In other words, there is a disruption 
of the harmonic interaction between astrocytes (glycolysis, 
lactate release, and glutamate uptake) and neurons (lactate 
uptake and its use as a fuel source in oxidative metabolism). 
But, it must be emphasized that the interactions between 
astrocytes and neurons involve not only glucose/lactate 
metabolism, but also neuroprotective mechanisms similar 
than that triggered during ischemia (Gouix et al., 2014), 
chronic hyperglycemia (Rivera-Aponte et al., 2015), and 
traumatic brain injury (Crupi et al., 2013).
Diazepam increases GABAergic inhibition of 
glutamatergic neurons (Lason, Chelebicka, Rejdak, 2013; 
Malhi et al., 2014) promote an anticonvulsant effect (Table 
III). Therefore, we suggest that an elevated availability 
of excitatory neurotransmitters could have triggered 
seizures and deaths (Sulkowski, Dabrowska-Bouta, 
Struzynsk, 2013). Consistent with this hypothesis, it was 
previously proposed that excitatory amino acid pathways 
may mediate the insulin-induced hypoglycemic seizures 
in Swiss mice (Anuradha, Hota, Pandhi, 2004). 
Finally, our results did not change the current view 
that lactate is the main energetic fuel to the neurons. 
However, in contrast with glucose, oral lactate intensifies 
insulin toxicity. 
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